Efficient nonviral transfection of dendritic cells and their use for in vivo immunization (Q73256735)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11101806%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Efficient nonviral transfection of dendritic cells and their use for in vivo immunization (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11101806%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

Irvine AS

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11101806%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Trinder PK

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11101806%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Laughton DL

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11101806%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Ketteringham H

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11101806%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

McDermott RH

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11101806%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Reid SC

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11101806%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Haines AM

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11101806%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Amir A

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11101806%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Husain R

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11101806%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Doshi R

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11101806%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Young LS

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11101806%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Mountain A

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11101806%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 December 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11101806%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11101806%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11101806%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11101806%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

1273-1278

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11101806%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/82383

2 November 2019

exact match

0 references

cites work

Proliferating dendritic cell progenitors in human blood

1 reference

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

7 January 2021

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

7 January 2021

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

1 reference

7 January 2021

Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA.

1 reference

7 January 2021

Enhanced therapeutic efficacy of tumor RNA-pulsed dendritic cells after genetic modification with lymphotactin

1 reference

7 January 2021

Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease

1 reference

7 January 2021

The central role of CD4(+) T cells in the antitumor immune response

1 reference

7 January 2021

The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses

1 reference

7 January 2021

Retrovirally transduced mouse dendritic cells require CD4+ T cell help to elicit antitumor immunity: implications for the clinical use of dendritic cells

1 reference

7 January 2021

Rapid effector function in CD8+ memory T cells

1 reference

7 January 2021

Class I MHC molecules rather than other mouse genes dictate influenza epitope recognition by cytotoxic T cells

1 reference

7 January 2021

Molecular characterization of a human tyrosinase-related-protein-2 cDNA. Patterns of expression in melanocytic cells

1 reference

7 January 2021

Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy

1 reference

7 January 2021

Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma

1 reference

7 January 2021

Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

1 reference

7 January 2021

Efficient transduction of mature CD83+ dendritic cells using recombinant adenovirus suppressed T cell stimulatory capacity

1 reference

7 January 2021

Transfer of antigen between dendritic cells in the stimulation of primary T cell proliferation

1 reference

7 January 2021

Dendritic cell-based genetic immunization in mice with a recombinant adenovirus encoding murine TRP2 induces effective anti-melanoma immunity

1 reference

7 January 2021

Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.

1 reference

7 January 2021

Repressor titration: a novel system for selection and stable maintenance of recombinant plasmids

1 reference

7 January 2021

Genetically modified bone marrow-derived dendritic cells expressing tumor-associated viral or "self" antigens induce antitumor immunity in vivo

1 reference

7 January 2021

Nomenclature for synthetic gene delivery systems.

1 reference

7 January 2021

A recombinant adenovirus expressing an Epstein-Barr virus (EBV) target antigen can selectively reactivate rare components of EBV cytotoxic T-lymphocyte memory in vitro

1 reference

7 January 2021

Identifiers

DOI

10.1038/82383

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11101806%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference